“…In recent years, fluorescent probes with red or near-infrared (NIR) emission (650–900 nm) for sensing analytes in biological matrixes have become more and more attractive due to the enhanced sample penetration and reduced background interference. , Current red–NIR fluorescent probes are mostly developed based on cyanines, rhodamine analogues, boron dipyrromethane, and dicyanomethylene-4 H -chromene (DCM) derivatives. , Among them, the benzene-incorporated DCM derivative (BDCM, Figure A) was broadly used in the design of red–NIR fluorescent probes because of its facile synthesis, ready modification, high fluorescence quantum yield, and photoresistance. , The neutral BDCM molecule is nonfluorescent, and the bright red–NIR emission originates from its ultrafast intramolecular charge transfer (ICT) when the phenolic hydroxyl is dissociated as phenoxide anion (Figure A) . Until now, BDCM has been developed as fluorescent probes for the detection of various analytes from small anions, to biothiols, − hydrogen peroxide, and enzymes. , Nevertheless, the p K a value of the phenolic hydroxyl of BDCM is estimated to be 9.85, indicating that the phenolic hydroxyl can only be ionized at relatively high pH value, which is usually beyond the pH range of biological systems. Consequently, the fluorescence of BDCM should be very weak at normal biomatrixes and is almost nonfluorescent in acidic biosamples such as tumor cells, urine, saliva, and sweat .…”